Viking Therapeutics, Inc.
Industry: Life Sciences ・ $VKTX on Nasdaq
Insider Sale
+$6,702,443
-4.69%
Shares
Shares Volume: 115,859 Shares
Average Share Price: $57.85
INSIDER
Lian Brian
President & CEO (Director)
reported on Jul 31 2024
traded on Jul 29 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 2,354,927 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $3,650,165.23 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 11 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $4,363,898.34 |
| COMPANY PREVIOUS TRADES |